United States Neurology Devices Medical Equipment Industry Repor

Published by: Global Markets Direct

Published: May. 2, 2008

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

2.2 Definitions

2.2.1 Neurology Devices

3 Healthcare Sector Review

3.1 Healthcare Expenditure

3.2 Healthcare Infrastructure

3.2.1 Healthcare Personnel Data

3.2.2 Healthcare Facilities Data

4 Neurology Devices in United States

4.1 Neurology Devices Overall Revenue (2000-2012)

4.2 Neurology Devices Overall Volume (2000-2012)

4.3 Neurology Devices Overall Company Share (2000-2012)

5 CSF Management in United States

5.1 CSF Management Category Revenue

5.1.1 Hydrocephalus Shunts Overall Revenues (2000-2012)

5.1.2 ICP Monitoring Devices Overall Revenues (2000-2012)

5.2 CSF Management Overall Volume (2000-2012)

5.2.1 Hydrocephalus Shunts Overall Volume (2000-2012)

5.2.2 ICP Monitoring Devices Overall Volume (2000-2012)

5.3 CSF Management Average Price (2000-2012)

5.3.1 Hydrocephalus Shunts Average Price (2000-2012)

5.3.2 ICP Monitoring Devices Average Price (2000-2012)

5.4 CSF Management Distribution Share (2005-2006)

5.5 CSF Management Company Share (2005-2006)

6 Radiosurgery in United States

6.1 Radiosurgery Overall Revenue (2000-2012)

6.2 Radiosurgery Overall Volume (2000-2012)

6.2.1 CyberKnife Radiosurgery Overall Volume (2000-2012)

6.2.2 GammaKnife Radiosurgery Overall Volume (2007-2012)

6.3 Radiosurgery Average Price (2000-2012)

6.3.1 CyberKnife Radio surgery Average Price (2000-2012)

6.3.2 GammaKnife Radio surgery Average Price (2000-2012)

6.4 Radiosurgery Distribution Share (2005-2006)

6.5 Radio Surgery Company Share (2006-2006)

7 Neurostimulation Devices in India

7.1 Neurostimulation Devices Overall Revenue (2000-2012)

7.1.1 Spinal Cord Stimulators Overall Revenues (2000-2012)

7.1.2 Deep Brain Stimulator Overall Revenues (2000-2012)

7.1.3 Vagus Nerve Stimulators Overall Revenues (2000-2012)

7.2 Neurostimulation Devices Overall Volume (2000-2012)

7.2.1 Spinal Cord Stimulator Overall Volume (2000-2012)

7.2.2 Deep Brain Stimulator Overall Volume (2000-2012)

7.2.3 Vagus Nerve Stimulators Overall Volume (2000-2012)

7.3 Neurostimulation Devices Average Price (2000-2012)

7.3.1 Spinal Cord Stimulator Average Price (2000-2012)

7.3.2 Deep Brain Stimulator Average Price (2000-2012)

7.3.3 Vagus Nerve Stimulator Average Price (2000-2012)

7.4 Neurostimulation Devices Distribution Share (2005-2006)

7.5 Neurostimulation Devices Company Share (2005-2006)

8 Interventional Neurology in United States

8.1 Interventional Neurology Overall Revenue (2000-2012)

8.1.1 Navigational System Overall Revenues (2000-2012)

8.1.2 Embolic System Overall Revenues (2000-2012)

8.1.3 Aneurism Clips Overall Revenues (2000-2012)

8.2 Interventional Neurology Overall Volume (2000-2012)

8.2.1 Embolic System Overall Volume (2000-2012)

8.2.2 Navigational System Overall Volume (2000-2012)

8.2.3 Aneurism Clips Overall Volume (2000-2012)

8.3 Interventional Neurology Average Price (2000-2012)

8.3.1 Aneurism Clips Average Price (2000-2012)

8.3.2 Embolic System Coils Average Price (2000-2012)

8.3.3 Navigational System Average Price (2000-2012)

8.4 Interventional Neurology Distribution Share (2005-2006)

8.5 Interventional Neurology Company Share (2005-2012)

9 Neuroendoscopes in United States

9.1 Neuroendoscopes Overall Revenue (2000-2012)

9.2 Neuroendoscopes Overall Volume (2000-2012)

9.3 Neuroendoscopes Average Price (2000-2012)

9.4 Neuroendoscopes Distribution Share (2005-2006)

9.5 Neurosurgical Products Company Share (2005-2006)

10 Elekta AB Company Profile

10.1 Company Overview

10.2 Business Overview

10.2.1 Treatment for Cancer and Brain disorder

10.2.2 Products

10.2.3 History

10.3 Value Chain Analysis

10.3.1 Manufacturing

10.3.2 Product Development

10.3.3 Sales and Marketing

10.4 SWOT Analysis

10.4.1 Elekta AB Strengths

10.4.2 Elekta AB Weaknesses

10.4.3 Elekta AB Opportunities

10.4.4 Elekta AB Threats

10.5 Financial and Operational Review

10.6 Locations And Subsidiaries

10.7 Financial Deals Landscape

10.7.1 Elekta Acquires CMS

10.7.2 Elekta Acquires 3D Line Medical Systems

10.7.3 Elekta Acquires 80% Equity Of Beijing Medical Equipment Institute

10.7.4 Elekta Signs An Agreement With CIVCO Medical Solutions (formerly known as MEDTEC)

10.7.5 Elekta Acquires Medical Intelligence Medizintechnik

10.7.6 Elekta Completes $125 Million Senior Note Private Placement

10.7.7 Elekta Acquires IMPAC Medical Systems

10.8 Recent Developments

10.8.1 Mar 10, 2008: Elekta To Deliver Brain Mapping Technology To Froedtert Hospital

10.9 Elekta AB Pipeline Products

10.9.1 Elekta Infinity

10.9.2 Elekta VMAT

11 Medtronic, Inc. Company Profile

11.1 Company Overview

11.2 Business Overview

11.2.1 Cardiac Surgery

11.2.2 CRDM

11.2.3 Diabetes

11.2.4 ENT

11.2.5 Neurological

11.2.6 Physio-Control

11.2.7 Spinal and Navigation

11.2.8 Vascular

11.2.9 Products

11.2.10 History

11.3 Value Chain Analysis

11.3.1 Manufacturing

11.3.2 Product Development

11.3.3 Sales and Marketing

11.4 SWOT Analysis

11.4.1 Medtronic, Inc. Strengths

11.4.2 Medtronic, Inc. Weaknesses

11.4.3 Medtronic, Inc. Opportunities

11.4.4 Medtronic, Inc. Threats

11.5 Financial and Operational Review

11.6 Locations And Subsidiaries

11.7 Financial Deals Landscape

11.7.1 Medtronic Enters Into Licensing Agreement With Arbor Surgical Technologies

11.7.2 Arbor Surgical Technologies Secures $20 Million In Series C Financing

11.7.3 REVA Medical Secures $42 Million In Financing

11.7.4 CardioMEMS Secures $33 Million In Series E Financing

11.7.5 Mitralign Secures $24 Million In Series C Financing

11.7.6 Medtronic Acquires Kyphon

11.7.7 Medtronic Acquires MRI Safety Patents From Biophan

11.7.8 Bayer HealthCare Diabetes Care Signs An Agreement With Medtronic

11.7.9 Alpine Acquires Neurodiagnostic Product Line From Medtronic

11.7.10 Medtronic Signs An Agreement With Axon Systems

11.7.11 Alpine Biomed Acquires Gastroenterology Diagnostics Product Line From Medtronic

11.7.12 Innerpulse Announces Closing Of $50 Million Series C Round

11.8 Recent Developments

11.8.1 Apr 08, 2008: Medtronic Settles Lawsuit With Spectranetics

11.8.2 Mar 19, 2008: FDA Calls Medtronic Drug Pump Warning Class I

11.8.3 Mar 05, 2008: Recent Medical Device Recall Indicates Need For Patient Protections

11.8.4 Mar 03, 2008: Medtronic Pays Akin Gump $140,000 To Lobby

11.8.5 Mar 01, 2008: Medtronic And Other Device Makers Support Disclosure Of Payments To Doctors

11.8.6 Feb 27, 2008: Medtronic Spends $1.7 Million On Lobbying In 2007

11.8.7 Feb 27, 2008: Medtronic Announces First Human Use Of Its Bifurcation Stent

11.8.8 Feb 26, 2008: Medtronic Says Sunshine Act Should Go Further

11.8.9 Feb 22, 2008: Medtronic Elects New Board Member

11.8.10 Feb 21, 2008: Medtronic Approves Cash Dividend

11.8.11 Feb 20, 2008: US Supreme Court Shields Medical Device Manufacturers From Consumer Lawsuits

11.8.12 Jan 28, 2008: Medtronic, Arbor Announce Exclusive Licensing Agreement

11.8.13 Jan 10, 2008: Medtronic Foundation Announces New Grant Guidelines For Its HeartRescue Program

11.8.14 Dec 21, 2007: Medtronic Resolves Marquis Defibrillator Lawsuits

11.8.15 Dec 17, 2007: Medtronic And Weigao Announce Joint Venture In China

11.8.16 Nov 15, 2007: Brower Piven Announces Class Action Lawsuit Against Medtronic

11.8.17 Oct 19, 2007: Medtronic Approves Cash Dividend

11.8.18 Aug 23, 2007: Medtronic Elects New President And CEO

11.8.19 Aug 23, 2007: Medtronic Declares Quarterly Dividend

11.8.20 Jun 22, 2007: Medtronic Elects New Directors

11.8.21 Jun 22, 2007: Medtronic Declares Quarterly Dividend

11.8.22 May 25, 2007: Biocompatibles Enters Agreement With Abbott

11.8.23 May 07, 2007: Biosense Announce Strategic Alliance With Medtronic

11.8.24 Jan 18, 2007: Medtronic Declares Quarterly Dividend

11.8.25 Jan 18, 2007: Medtronic Elects New Board Member

11.8.26 Jan 23, 2006: Edwards Lifesciences and Medtronic Settles Infringement Lawsuit

11.9 Medtronic, Inc. Pipeline Products

11.9.1 BRYAN Cervical Disc

11.9.2 Endeavor Drug-Eluting Stent

11.9.3 Medtronic Implantable Cardioverter Defibrillators

11.9.4 EnRhythm MRI SureScan Pacing System

11.9.5 DIAM Spinal Stabilization System

11.9.6 Endurant Stent Graft System

11.9.7 Talent Thoracic Stent Graft System

11.9.8 PIVOTAL AAA

11.9.9 Exponent RX Self-Expanding Carotid Stent

11.9.10 GuardWire embolic protection system

11.9.11 Deep Brain Stimulation (DBS) therapy

11.9.12 Melody Transcatheter Pulmonary Valve

11.9.13 Chronicle ICD

11.9.14 Advantage Supra

11.9.15 Pulmonic TCV

11.9.16 Percutaneous AAA

11.9.17 TGF Beta 1 Stent

11.9.18 Cinched Mosaic

11.9.19 LAA Occluder Band

11.9.20 Prestige LP

11.9.21 A-Mav

11.9.22 Interceptor PLUS Coronary Filter System

11.9.23 Sprint Quattro(Model 6944)

11.9.24 Sprint Quattro(Model 6947)

11.9.25 Valiant Thoracic Stent Graft

11.9.26 Intercept Epilepsy Control System

11.9.27 Bifurcation stent

11.9.28 Single-coil Quattro lead

11.9.29 OneTouch Glucose Meter

11.9.30 Next Generation Insulin Pump

11.9.31 Pre-filled Insulin Reservoirs

11.9.32 Implantable Insulin Pump

12 Accuray Incorporated Company Profile

12.1 Company Overview

12.2 Business Overview

12.2.1 Other

12.2.2 Products

12.2.3 Services

12.2.4 Shared Ownership Program

12.2.5 Products

12.2.6 History

12.3 Value Chain Analysis

12.3.1 Manufacturing

12.3.2 Product Development

12.3.3 Sales and Marketing

12.4 SWOT Analysis

12.4.1 Accuray Incorporated Strengths

12.4.2 Accuray Incorporated Weaknesses

12.4.3 Accuray Incorporated Opportunities

12.4.4 Accuray Incorporated Threats

12.5 Financial and Operational Review

12.6 Locations And Subsidiaries

12.7 Financial Deals Landscape

12.7.1 Alliance Imaging Acquires Six Radiosurgery CyberKnife Stereotactic Facilities From Accuray

12.7.2 Accuray Enters Into A License Agreement With Cyberheart

12.7.3 Accuray Signs Distribution And Co-Marketing Agreement With Siemens

12.7.4 Accuray Incorporated Completes IPO

12.7.5 Accuray Incorporated Acquires Certain Assets Of American Science and Engineering

12.8 Recent Developments

12.8.1 Feb 08, 2007: Accuray Announces Pricing Of Initial Public Offering

13 Codman & Shurtleff, Inc. Company Profile

13.1 Company Profile

13.1.1 Products

13.2 Locations And Subsidiaries

14 Cyberonics, Inc. Company Profile

14.1 Company Overview

14.2 Business Overview

14.2.1 Products

14.3 Locations And Subsidiaries

14.4 Financial Deals Landscape

14.4.1 Cyberonics And Ethicon Endo-Surgery Enter Into License Agreement

14.4.2 Boston Scientific Sells Its Stake In Cyberonics

14.4.3 Carl Icahn Acquires 2% Stake In Cyberonics

14.4.4 Cyberonics Completes Private Placement

14.4.5 Advanced Neuromodulation Systems Sells Its Stake In Cyberonics

14.5 Recent Developments

14.5.1 Jul 09, 2007: Cyberonics Appoints New CFO

14.5.2 Jun 11, 2007: Cyberonics Declares Fiscal 2007 Results

14.5.3 Jun 11, 2007: Cyberonics Reports Fiscal Year 2007 Results

14.5.4 May 01, 2007: Cyberonics Appoints New CEO

14.5.5 May 01, 2007: Cyberonics Appoints New CEO

14.5.6 Jan 29, 2007: Cyberonics Announces Board Changes

14.5.7 Jan 29, 2007: Cyberonics Announces Board Changes

15 Regulation System

15.1 Medical Equipment Approval Process

15.1.1 Pre-market Approval Process

15.1.2 Intended use and Indications for use

15.1.3 Predicate Device

15.1.4 Safe and Effective

15.1.5 Other Category Devices

15.1.6 Post-Market Approval Process

15.1.7 Compliance and Enforcement

15.1.8 Registration Fee

15.1.9 Approval Time

16 Pricing and Reimbursement

16.1 Government Policies

16.2 Private Insurance

16.3 Diagnosis Related Groups (DRG)

17 Distribution Structure

17.1 Distribution Structure

18 APPENDIX

18.1 Global Markets Direct Research Methodology

18.2 Coverage

18.3 Secondary Research

18.4 Primary Research

18.5 Models

18.6 Forecasts

18.7 Expert Panels

18.8 Currency Conversion

18.9 Contact Us

18.10 Disclaimer

1.1 List of Tables

Table 1: United States Healthcare Expenditure, 2003-2010

Table 2: United States Healthcare Expenditure by Age (per person), 2000-2003

Table 3: United States Healthcare Expenditure by Sex (per person), 2000-2003

Table 4: United States Healthcare Expenditure by Race (per person), 2000-2003

Table 5: United States Personal Healthcare Expenditure by Type, 2000-2004

Table 6: United States Personal Healthcare Expenditure by Source, 2000-2004

Table 7: Total Number of Doctors in the United States, 2003-2010

Table 8: Number of Doctors by Specialty in the United States, 2003-2010

Table 9: Doctors by Region (Number per 10,000 Civilian Population), 2002-2004

Table 10: Doctors by Region (Number per 10,000 Civilian Population), 2002-2004 (Cont.)

Table 11: Total Hospitals in the United States, 2000-2004

Table 12: Community Hospitals by Number of Beds in the United States, 2000-2004

Table 13: Number of Hospital Beds in the United States, 2000-2004

Table 14: Number of Hospital Beds by Range in the United States, 2000-2004

Table 15: Neurology Devices, United States, Overall Revenues ($ mn), 2000-2012

Table 16: Neurology Devices, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 17: Neurology Devices, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 18: Neurology Devices, United States, Category Revenues ($ mn), 2000-2012

Table 19: Neurology Devices, United States, Category Revenues ($ mn), Historic, 2000-2007

Table 20: Neurology Devices, United States, Category Revenues ($ mn), Forecast, 2007-2012

Table 21: Neurology Devices, United States, Category Volume (Units), 2000-2012

Table 22: Neurology Devices, United States, Category Volume (Units), Historic, 2000-2007

Table 23: Neurology Devices, United States, Category Volume (Units), Forecast, 2007-2012

Table 24: Neurology Devices, United States, Company Share by Revenue ($ mn), 2005-2006

Table 25: CSF Management, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 26: CSF Management, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 27: CSF Management, United States, Revenue by Segment ($ mn), Historic, 2000-2007

Table 28: CSF Management, United States, Revenue by Segment ($ mn), Forecast, 2007-2012

Table 29: Hydrocephalus Shunts, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 30: Hydrocephalus Shunts, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 31: ICP Monitoring Devices, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 32: ICP Monitoring Devices, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 33: CSF Management, United States, Overall Volume (Units), Historic, 2000-2007

Table 34: CSF Management, United States, Overall Volume (Units), Forecast, 2007-2012

Table 35: Hydrocephalus Shunts, United States, Overall Volume (Units), Historic, 2000-2007

Table 36: Hydrocephalus Shunts, United States, Overall Volume (Units), Forecast, 2007-2012

Table 37: ICP Monitoring Devices, United States, Overall Volume (Units), Historic, 2000-2007

Table 38: ICP Monitoring Devices, United States, Overall Volume (Units), Forecast, 2007-2012

Table 39: Hydrocephalus Shunts, United States, Average Price ($), Historic, 2000-2007

Table 40: Hydrocephalus Shunts, United States, Average Price ($), Forecast, 2007-2012

Table 41: ICP Monitoring Devices, United States, Average Price ($), Historic, 2000-2007

Table 42: ICP Monitoring Devices, United States, Average Price ($), Forecast, 2007-2012

Table 43: CSF Management, United States, Distribution Share by Revenue ($ mn), 2005-2006

Table 44: CSF Management, United States, Company Share by Revenue ($ mn), 2005-2006

Table 45: Radiosurgery, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 46: Radiosurgery, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 47: Radiosurgery, United States, Revenue by Segment ($ mn), Historic, 2000-2007

Table 48: Radiosurgery, United States, Revenue by Segment ($ mn), Forecast, 2007-2012

Table 49: GammaKnife Radiosurgery, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 50: GammaKnife Radiosurgery, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 51: CyberKnife Radiosurgery, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 52: CyberKnife Radiosurgery, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 53: Radiosurgery, United States, Overall Volume (Units), Historic, 2000-2007

Table 54: Radiosurgery, United States, Overall Volume (Units), Forecast, 2007-2012

Table 55: CyberKnife Radiosurgery, United States, Overall Volume (Units), Historic, 2000-2007

Table 56: CyberKnife Radiosurgery, United States, Overall Volume (Units), Forecast, 2007-2012

Table 57: GammaKnife Radiosurgery, United States, Overall Volume (Units), Historic, 2000-2007

Table 58: CyberKnife Radiosurgery, United States, Overall Volume (Units), Forecast, 2007-2012

Table 59: CyberKnife Radiosurgery, United States, Average Price ($), Historic, 2000-2007

Table 60: CyberKnife Radiosurgery, United States, Average Price ($), Forecast, 2007-2012

Table 61: GammaKnife Radio Surgery, United States, Average Price ($), Historic, 2000-2007

Table 62: GammaKnife Radio Surgery, United States, Average Price ($), Forecast, 2007-2012

Table 63: Radio Surgery, United States, Distribution Share by Revenue ($ mn), 2005-2006

Table 64: Radio Surgery, United States, Company Share by Revenue ($ mn), 2005-2006

Table 65: Neurostimulation Devices, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 66: Neurostimulation Devices, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 67: Neurostimulation Devices, United States, Revenue by Segment ($ mn), Historic, 2000-2007

Table 68: Neurostimulation Devices, United States, Revenue by Segment ($ mn), Forecast, 2007-2012

Table 69: Spinal Cord Stimulators, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 70: Spinal Cord Stimulators, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 71: Deep Brain Stimulator, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 72: Deep Brain Stimulator, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 73: Vagus Nerve Stimulators, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 74: Vagus Nerve Stimulators, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 75: Neurostimulation Devices, United States, Overall Volume (Units), Historic, 2000-2007

Table 76: Neurostimulation Devices, United States, Overall Volume (Units), Forecast, 2007-2012

Table 77: Spinal Cord Stimulators, United States, Overall Volume (Units), Historic, 2000-2007

Table 78: Spinal Cord Stimulators, United States, Overall Volume (Units), Forecast, 2007-2012

Table 79: Deep Brain Stimulator, United States, Overall Volume (Units), Historic, 2000-2007

Table 80: Deep Brain Stimulator, United States, Overall Volume (Units), Forecast, 2007-2012

Table 81: Vagus Nerve Stimulators, United States, Overall Volume (Units), Historic, 2000-2007

Table 82: Vagus Nerve Stimulators, United States, Overall Volume (Units), Forecast, 2007-2012

Table 83: Spinal Cord Stimulators, United States, Average Price ($), Historic, 2000-2007

Table 84: Spinal Cord Stimulators, United States, Average Price ($), Forecast, 2007-2012

Table 85: Deep Brain Stimulators, United States, Average Price ($), Historic, 2000-2007

Table 86: Deep Brain Stimulators, United States, Average Price ($), Forecast, 2007-2012

Table 87: Vagus Nerve Stimulators, United States, Average Price ($), Historic, 2000-2007

Table 88: Vagus Nerve Stimulators, United States, Average Price ($), Forecast, 2007-2012

Table 89: Neurostimulation Devices, United States, Distribution Share by Revenue ($ mn), 2005-2006

Table 90: Neurostimulation Devices, United States, Company Share by Revenue ($ mn), 2005-2006

Table 91: Interventional Neurology, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 92: Interventional Neurology, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 93: Interventional Neurology, United States, Revenue by Segment ($ mn), Historic, 2000-2007

Table 94: Interventional Neurology, United States, Revenue by Segment ($ mn), Forecast, 2007-2012

Table 95: Navigational System, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 96: Navigational System, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 97: Navigational System, United States, Revenues by Sub-segment($ mn), Historic, 2000-2007

Table 98: Navigational System, United States, Revenues by Sub-segment($ mn), Forecast, 2007-2012

Table 99: Navigational Catheters, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 100: Navigational Catheters, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 101: Guidewires, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 102: Guidewires, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 103: Embolic System, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 104: Embolic System, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 105: Embolic System, United States, Revenues by Sub-segment($ mn), Historic, 2000-2007

Table 106: Embolic System, United States, Revenues by Sub-segment($ mn), Forecast, 2007-2012

Table 107: Embolization Coils, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 108: Embolization Coils, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 109: Liquid Embolic Systems, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 110: Liquid Embolic Systems, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 111: Aneurysm Clips, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 112: Aneurysm Clips, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 113: Interventional Neurology, United States, Overall Volume (Units), Historic, 2000-2007

Table 114: Interventional Neurology, United States, Overall Volume (Units), Forecast, 2007-2012

Table 115: Embolic System, United States, Overall Volume (Units), Historic, 2000-2007

Table 116: Embolic System, United States, Overall Volume (Units), Forecast, 2007-2012

Table 117: Embolic System, United States, Volume by Subsegment (Units), Historic, 2000-2007

Table 118: Embolic System, United States, Volume by Subsegment (Units), Forecast, 2007-2012

Table 119: Liquid Embolic Systems, United States, Overall Volume (Units), Historic, 2000-2007

Table 120: Liquid Embolic Systems, United States, Overall Volume (Units), Forecast, 2007-2012

Table 121: Embolization Coils, United States, Overall Volume (Units), Historic, 2000-2007

Table 122: Embolization Coils, United States, Overall Volume (Units), Forecast, 2007-2012

Table 123: Navigational System, United States, Overall Volume (Units), Historic, 2000-2007

Table 124: Navigational System, United States, Overall Volume (Units), Forecast, 2007-2012

Table 125: Navigational System, United States, Volume by Subsegment (Units), Historic, 2000-2007

Table 126: Navigational System, United States, Volume by Subsegment (Units), Forecast, 2007-2012

Table 127: Navigational Catheters, United States, Overall Volume (Units), Historic, 2000-2007

Table 128: Navigational Catheters, United States, Overall Volume (Units), Forecast, 2007-2012

Table 129: Guidewires, United States, Overall Volume (Units), Historic, 2000-2007

Table 130: Guidewires, United States, Overall Volume (Units), Forecast, 2007-2012

Table 131: Aneurysm Clips, United States, Overall Volume (Units), Historic, 2000-2007

Table 132: Aneurysm Clips, United States, Overall Volume (Units), Forecast, 2007-2012

Table 133: Aneurysm Clips, United States, Average Price ($), Historic, 2000-2007

Table 134: Aneurysm Clips, United States, Average Price ($), Forecast, 2007-2012

Table 135: Embolization Coils, United States, Average Price ($), Historic, 2000-2007

Table 136: Embolization Coils, United States, Average Price ($), Forecast, 2007-2012

Table 137: Liquid Embolic Systems, United States, Average Price ($), Historic, 2000-2007

Table 138: Liquid Embolic Systems, United States, Average Price ($), Forecast, 2007-2012

Table 139: Navigational Catheters, United States, Average Price ($), Historic, 2000-2012

Table 140: Navigational Catheters, United States, Average Price ($), Forecast, 2007-2012

Table 141: Guidewires, United States, Average Price ($), Historic, 2000-2007

Table 142: Guidewires, United States, Average Price ($), Forecast, 2007-2012

Table 143: Interventional Neurology, United States, Distribution Share by Revenue ($ mn), 2005-2006

Table 144: Interventional Neurology, United States, Company Share by Revenue ($ mn), 2005-2006

Table 145: Neuroendoscopes, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 146: Neuroendoscopes, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 147: Neuroendoscopes, United States, Overall Volume (Units), Historic, 2000-2007

Table 148: Neuroendoscopes, United States, Overall Volume (Units), Forecast, 2007-2012

Table 149: Neuroendoscopes, United States, Average Price ($), Historic, 2000-2007

Table 150: Neuroendoscopes, United States, Average Price ($), Forecast, 2007-2012

Table 151: Neuroendoscopes, United States, Distribution Share by Revenue ($ mn), 2005-2006

Table 152: Neuroendoscopes, United States, Company Share by Revenue ($ mn), 2005-2006

Table 153: Elekta AB, SWOT Analysis, 2007

Table 154: Elekta AB, Financial Statements, SEK Million, 2003-2007

Table 155: Elekta AB, Financial Ratios, SEK Million, 2003-2007

Table 156: Elekta AB, Other Locations

Table 157: Elekta AB, Other Locations,(Cont.)

Table 158: Elekta AB, Subsidiaries

Table 159: Medtronic, Inc., SWOT Analysis, 2007

Table 160: Medtronic, Inc., Financial Statements, USD Million, 2003-2007

Table 161: Medtronic, Inc., Financial Ratios, USD Million, 2003-2007

Table 162: Medtronic, Inc., Other Locations

Table 163: Medtronic, Inc., Subsidiaries

Table 164: Accuray Incorporated, SWOT Analysis, 2007

Table 165: Accuray Incorporated, Financial Statements, USD Thousand, 2003-2007

Table 166: Accuray Incorporated, Financial Ratios, USD Thousand, 2003-2007

Table 167: Accuray Incorporated, Other Locations

Table 168: Codman & Shurtleff, Inc., Other Locations

Table 169: Cyberonics, Inc., Subsidiaries

Table 170: Medical Equipment Registration Fee in United States, 2007

Table 171: Medical Device Approval Time in United States, 2004

Table 172: Currency Conversion from USD to Local Currency at 2007 Constant Rate

1.2 List of Figures

Figure 1: United States, Healthcare Expenditure by Source, 2003

Figure 2: United States, Healthcare Infrastructure, Top Level View, 2007

Figure 3: Healthcare Expenses Segmentation by End User, 2003

Figure 4: Neurology Devices, United States, Overall Revenues ($ mn), 2000-2012

Figure 5: Neurology Devices, United States, Overall Revenues ($ mn), Historic, 2000-2007

Figure 6: Neurology Devices, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 7: Neurology Devices, United States, Category Revenues ($ mn), 2000-2012

Figure 8: Neurology Devices, United States, Category Revenues ($ mn), Historic, 2000-2007

Figure 9: Neurology Devices, United States, Category Revenues ($ mn), Forecast, 2007-2012

Figure 10: Neurology Devices, United States, Company Share (%), 2006

Figure 11: CSF Management, United States, Overall Revenues ($ mn), Historic, 2000-2007

Figure 12: CSF Management, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 13: CSF Management, United States, Revenue by Segment ($ mn), Historic, 2000-2007

Figure 14: CSF Management, United States, Revenue by Segment ($ mn), Forecast, 2007-2012

Figure 15: Hydrocephalus Shunts, United States, Overall Revenues ($ mn), Historic, 2000-2007

Figure 16: Hydrocephalus Shunts, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 17: ICP Monitoring Devices, United States, Overall Revenues ($ mn), Historic, 2000-2007

Figure 18: ICP Monitoring Devices, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 19: CSF Management, United States, Overall Volume (Units), Historic, 2000-2007

Figure 20: CSF Management, United States, Overall Volume (Units), Forecast, 2007-2012

Figure 21: Hydrocephalus Shunts, United States, Overall Volume (Units), Historic, 2000-2007

Figure 22: Hydrocephalus Shunts, United States, Overall Volume (Units), Forecast, 2007-2012

Figure 23: ICP Monitoring Devices, United States, Overall Volume (Units), Historic, 2000-2007

Figure 24: ICP Monitoring Devices, United States, Overall Volume (Units), Forecast, 2007-2012

Figure 25: Hydrocephalus Shunts, United States, Average Price ($), Historic, 2000-2007

Figure 26: Hydrocephalus Shunts, United States, Average Price ($), Forecast, 2007-2012

Figure 27: ICP Monitoring Devices, United States

Abstract

• The report provides sector information broken down into detailed categories and segments in country.
• Total revenues, products sold, end users, and average pricing.
• Market shares of all the key competitors.
• Key pipeline products that are set to shape the market, broken down by sector.
• Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
• Key mergers and acquisitions, partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

• Gain a strong understanding of the industry at a global level, with break downs for the country
• Evaluate and compare the attractiveness of the market in the country.
• Identify growth segments and opportunities in each industry sector within the country.
• Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
• Analyze the competitiveness of the market in the country and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the country.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
• Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.